✦ LIBER ✦

Use of cefepime for the treatment of infections caused by extended spectrum β-lactamase–producing Klebsiella pneumoniae and Escherichia coli

✍ Scribed by Vincent J. LaBombardi; Albert Rojtman; Kim Tran

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk-factors for emerging bloodstream in

✍ J. Rodríguez-Baño; M. D. Navarro; L. Romero; M. A. Muniain; M. de Cueto; J. Gálv 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Piperacillin–tazobactam as an initial em

✍ Cheol-In Kang; So Yeon Park; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Investigation of extended-spectrum β-lac

✍ S.H. Jeong; I.K. Bae; S.B. Kwon; J.H. Lee; H.I. Jung; J.S. Song; B.C. Jeong; S.- 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Clinical outcomes and therapeutic option

✍ Gokhan Metan; Pınar Zarakolu; Banu Çakır; Gulsen Hascelik; Omrum Uzun 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Impact of Extended-spectrum β-lactamase-

✍ Ya-Sung Yang; Chih-Hung Ku; Jung-Chung Lin; Shih-Ta Shang; Chun-Hsiang Chiu; Kuo 📂 Article 📅 2010 🏛 Scientific Communications 🌐 English ⚖ 334 KB

In Vitro Activity of Cefepime, Imipenem,

✍ Raymond Cha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB